Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 3459730, 2 pages
http://dx.doi.org/10.1155/2016/3459730
Editorial

Towards Creating the Perfect In Vitro Cell Model

1Genome Institute of Singapore, 60 Biopolis Street, Genome, Singapore 138672
2Department of Medical Physiology, Division of Heart & Lungs, UMC Utrecht, 3584 CM Utrecht, Netherlands
3Systems Biology Research Center, University of Skövde, 541 28 Skövde, Sweden
4Department of Psychiatry and Neurochemistry, Sahlgrenska University Hospital, 431 80 Mölndal, Sweden

Received 13 December 2015; Accepted 13 December 2015

Copyright © 2016 Malin K. B. Jonsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. K. B. Jonsson, T. A. B. van Veen, M.-J. Goumans, M. A. Vos, G. Duker, and P. Sartipy, “Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes,” Expert Opinion on Drug Discovery, vol. 4, no. 4, pp. 357–372, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. Oh, T.-C. Hsi, C. F. Guerrero-Juarez, R. Ramos, and M. V. Plikus, “Organotypic skin culture,” Journal of Investigative Dermatology, vol. 133, no. 11, pp. 1–4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Waring, J. Arrowsmith, A. R. Leach et al., “An analysis of the attrition of drug candidates from four major pharmaceutical companies,” Nature Reviews Drug Discovery, vol. 14, no. 7, pp. 475–486, 2015. View at Publisher · View at Google Scholar
  4. K. R. Chi, “Revolution dawning in cardiotoxicity testing,” Nature Reviews Drug Discovery, vol. 12, no. 8, pp. 565–567, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Takahashi, K. Tanabe, M. Ohnuki et al., “Induction of pluripotent stem cells from adult human fibroblasts by defined factors,” Cell, vol. 131, no. 5, pp. 861–872, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Thomson, J. Itskovitz-Eldor, S. S. Shapiro et al., “Embryonic stem cell lines derived from human blastocysts,” Science, vol. 282, no. 5391, pp. 1145–1147, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Holmgren, A.-K. Sjögren, I. Barragan et al., “Long-term chronic toxicity testing using human pluripotent stem cell-derived hepatocytes,” Drug Metabolism and Disposition, vol. 42, no. 9, pp. 1401–1406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Sakaguchi, T. Kadoshima, M. Soen et al., “Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue,” Nature Communications, vol. 6, article 8896, 2015. View at Publisher · View at Google Scholar
  9. E. Matsa, J. E. Dixon, C. Medway et al., “Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes,” European Heart Journal, vol. 35, no. 16, pp. 1078–1087, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Karakikes, F. Stillitano, M. Nonnenmacher et al., “Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy,” Nature Communications, vol. 6, article 6955, 2015. View at Publisher · View at Google Scholar
  11. R. E. Schwartz, H. E. Fleming, S. R. Khetani, and S. N. Bhatia, “Pluripotent stem cell-derived hepatocyte-like cells,” Biotechnology Advances, vol. 32, no. 2, pp. 504–513, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. L. Goulburn, E. G. Stanley, A. G. Elefanty, and S. A. Anderson, “Generating GABAergic cerebral cortical interneurons from mouse and human embryonic stem cells,” Stem Cell Research, vol. 8, no. 3, pp. 416–426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Soria, B. R. Gauthier, F. Martin et al., “Using stem cells to produce insulin,” Expert Opinion on Biological Therapy, vol. 15, no. 10, pp. 1469–1489, 2015. View at Google Scholar